These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16602118)

  • 21. Continuous increase in erythropoietic activity despite the improvement in bone mineral density by zoledronic acid in patients with thalassemia intermedia-induced osteoporosis.
    Voskaridou E; Christoulas D; Antoniadou L; Terpos E
    Acta Haematol; 2008; 119(1):40-4. PubMed ID: 18253025
    [No Abstract]   [Full Text] [Related]  

  • 22. Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial.
    Voskaridou E; Christoulas D; Konstantinidou M; Tsiftsakis E; Alexakos P; Terpos E
    Haematologica; 2008 Oct; 93(10):1588-90. PubMed ID: 18698086
    [No Abstract]   [Full Text] [Related]  

  • 23. [Relationship between growth disorders and iron overload in children with beta-thalassemia major].
    Huang YL; Liu S; Xia T; Hao WG; Liang W; Sun X
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):603-6. PubMed ID: 18947480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of calcitonin therapy on osteoporosis in patients with thalassemia.
    Canatan D; Akar N; Arcasoy A
    Acta Haematol; 1995; 93(1):20-4. PubMed ID: 7725845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulant system activity in splenectomized versus non-splenectomized Iranian patients with beta-thalassemia major.
    Rashidi A; Alavi S; Arzanian MT; Ahmadinejad M
    Pediatr Hematol Oncol; 2007 Dec; 24(8):645-7. PubMed ID: 18092257
    [No Abstract]   [Full Text] [Related]  

  • 26. Endocrine complications in patients with Thalassaemia Major.
    Toumba M; Sergis A; Kanaris C; Skordis N
    Pediatr Endocrinol Rev; 2007 Dec; 5(2):642-8. PubMed ID: 18084158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of a case manager to improve osteoporosis treatment after hip fracture: results of a randomized controlled trial.
    Majumdar SR; Beaupre LA; Harley CH; Hanley DA; Lier DA; Juby AG; Maksymowych WP; Cinats JG; Bell NR; Morrish DW
    Arch Intern Med; 2007 Oct; 167(19):2110-5. PubMed ID: 17954806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender differences in the prevalence and severity of bone disease in thalassaemia.
    Kyriakou A; Savva SC; Savvides I; Pangalou E; Ioannou YS; Christou S; Skordis N
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind, placebo-controlled trial of intravenous zoledronic acid in the treatment of thalassemia-associated osteopenia.
    Gilfillan CP; Strauss BJ; Rodda CP; Bowden DK; Kean AM; Obaid M; Crawford BA
    Calcif Tissue Int; 2006 Sep; 79(3):138-44. PubMed ID: 16969592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone and maxillofacial abnormalities in thalassemia: a review of the literature.
    Di Matteo R; Liuzza F; Manicone PF; Raffaelli L; Berardi D; Perfetti G; Maccauro G
    J Biol Regul Homeost Agents; 2008; 22(4):211-6. PubMed ID: 19036222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous zoledronic acid treatment in thalassemia-induced osteoporosis: results of a phase II clinical trial.
    Otrock ZK; Azar ST; Shamseddeen WA; Habr D; Inati A; Koussa S; Mahfouz RA; Taher AT
    Ann Hematol; 2006 Sep; 85(9):605-9. PubMed ID: 16830143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-thalassemia: the Lebanese experience.
    Inati A; Zeineh N; Isma'eel H; Koussa S; Gharzuddine W; Taher A
    Clin Lab Haematol; 2006 Aug; 28(4):217-27. PubMed ID: 16898958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival, mortality, and complications in patients with beta-thalassemia major in northern Taiwan.
    Chern JP; Su S; Lin KH; Chang SH; Lu MY; Jou ST; Lin DT; Ho WL; Lin KS
    Pediatr Blood Cancer; 2007 May; 48(5):550-4. PubMed ID: 16972241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Bone Metabolism Alterations in Transfusion-dependent Beta-thalassemia Major: An Observational Study.
    Murtas A; Zanza C; Vacca N; Saderi L; Sotgiu G; Fozza C; Antonucci R
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):118-119. PubMed ID: 32815882
    [No Abstract]   [Full Text] [Related]  

  • 35. Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy.
    El-Beshlawy A; Youssry I; El-Saidi S; El Accaoui R; Mansi Y; Makhlouf A; Taher A
    Pediatr Hematol Oncol; 2008 Dec; 25(8):734-43. PubMed ID: 19065439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
    Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
    Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cross-sectional study of bone mineral density in children and adolescents attending a Cystic Fibrosis Centre.
    Conway SP; Oldroyd B; Brownlee KG; Wolfe SP; Truscott JG
    J Cyst Fibros; 2008 Nov; 7(6):469-76. PubMed ID: 18573696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation of cortisol levels and bone mineral density among premenopausal women with major depression.
    Altindag O; Altindag A; Asoglu M; Gunes M; Soran N; Deveci Z
    Int J Clin Pract; 2007 Mar; 61(3):416-20. PubMed ID: 17313608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of treatment in specialized centers on survival of patients with thalassemia major.
    Forni GL; Puntoni M; Boeri E; Terenzani L; Balocco M
    Am J Hematol; 2009 May; 84(5):317-8. PubMed ID: 19396857
    [No Abstract]   [Full Text] [Related]  

  • 40. Intracranial calcification in beta-thalassemia major.
    Verma S; Saxena AK; Marwaha RK
    Indian Pediatr; 2007 Nov; 44(11):856-8. PubMed ID: 18057485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.